Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2025 | $62.00 → $65.00 | Market Perform → Outperform | BMO Capital Markets |
| 8/7/2024 | $58.00 | Market Perform → Market Outperform | CJS Securities |
| 4/22/2024 | $52.00 → $62.00 | Hold → Buy | Jefferies |
| 11/6/2023 | $49.00 | Market Outperform → Market Perform | CJS Securities |
| 10/3/2023 | $62.00 → $53.00 | Buy → Hold | Loop Capital |
| 8/7/2023 | $71.00 → $60.00 | Outperform → Market Perform | BMO Capital Markets |
| 7/27/2023 | $64.00 → $75.00 | Hold → Buy | Loop Capital |
| 5/5/2023 | $92.00 → $64.00 | Buy → Hold | Loop Capital |
BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously
CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00
Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously
4 - Ingevity Corp (0001653477) (Issuer)
4 - Ingevity Corp (0001653477) (Issuer)
3 - Ingevity Corp (0001653477) (Issuer)
10-K - Ingevity Corp (0001653477) (Filer)
8-K - Ingevity Corp (0001653477) (Filer)
8-K - Ingevity Corp (0001653477) (Filer)
Highlights: Strong business performance in 2025 drove higher earnings and robust cash flow, enabling meaningful debt reduction and return of capital to shareholders Completed sale of North Charleston crude tall oil refinery assets and the majority of Performance Chemicals Industrial Specialties product line Concluded portfolio review and initiated the exploration of strategic alternatives for Advanced Polymer Technologies segment and the Performance Chemicals Road Markings product line Full Year: Total net sales of $1.3 billion, from continuing and discontinued operations, decreased 8% from prior year; net sales from continuing operations of $1.2 billion, down 3% versus prior
GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals, as well as Specialty Chemicals investing. Attendees will also have the opportunity to participate in one-on-one meetings with management teams, available upon request. For those who cannot attend in person, access to the symposium will be available via webcast. Investors should contact their Gabelli relations
Founding directors Daniel F. Sansone and Jean S. Blackwell to conclude board service at the 2026 Annual Meeting Ingevity Corporation (NYSE:NGVT) today announced that two long-serving directors, Daniel F. Sansone and Jean S. Blackwell, will not stand for re-election at the company's 2026 Annual Meeting of Stockholders. Sansone, a founding director since Ingevity became a public company in 2016, is ending his service at the annual meeting in accordance with the board's mandatory retirement age policy. Blackwell, also a founding director, will conclude her tenure at the annual meeting following ten years of service. She previously served as chair of the board and provided essential leaders
Ingevity Corporation (NYSE:NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future. Chief financial officer transition Mary Dean Hall, executive vice president and chief financial officer (CFO), will transition from her current role effective May 1, 2026, and continue to support the company in an advisory capacity for a period of one year. Hall has served as CFO since 2021, playing a critical role in strengthening Ingevity's financial foundation, enhancing operational discipline and supporting strategic growth initiatives. Under her financial leadership, the company achieved significant margin expan
Veteran industry leader joins Ingevity to accelerate innovation and strategic growth across company's high performance activated carbon portfolio Ingevity Corporation (NYSE:NGVT) today announced that, effective November 10, 2025, Ruth Castillo has been appointed as president of Performance Materials, the company's unique activated carbon segment which has a long track record of consistent strong financial performance. She will also join Ingevity's executive leadership team as senior vice president. Castillo most recently served as vice president of global chemicals at Avantor. She brings more than 25 years of global experience in the chemicals and materials industries, with proven abili
Ingevity Corporation (NYSE:NGVT) today announced Ed Woodcock, executive vice president and president, Performance Materials, departed the company effective July 1, 2025. Woodcock's departure follows a 37-year career with the company. "Ed Woodcock's leadership has been foundational to the successful growth of Ingevity's Performance Materials activated carbon business as the industry leader in automotive emissions capture," said Ingevity president and CEO, Dave Li. "During his extensive career with the company, Ed drove global expansion of the business, delivered consistently strong profitability and positioned the Performance Materials segment for growth in the hybrid and electric vehicle
Highlights: Strong business performance in 2025 drove higher earnings and robust cash flow, enabling meaningful debt reduction and return of capital to shareholders Completed sale of North Charleston crude tall oil refinery assets and the majority of Performance Chemicals Industrial Specialties product line Concluded portfolio review and initiated the exploration of strategic alternatives for Advanced Polymer Technologies segment and the Performance Chemicals Road Markings product line Full Year: Total net sales of $1.3 billion, from continuing and discontinued operations, decreased 8% from prior year; net sales from continuing operations of $1.2 billion, down 3% versus prior
Ingevity Corporation (NYSE:NGVT) announced today that it will release its fourth quarter and full year 2025 earnings after the stock market close on Wednesday, February 25, 2026. The company will host a live webcast on Thursday, February 26, at 10:00 a.m. (Eastern) to discuss fourth quarter and full year 2025 fiscal results. The webcast can be accessed via the investors section of Ingevity's website. Participants may pre-register for the event here. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 102386. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recordin
Potential divestitures would further enhance portfolio to focus on core businesses which carry best-in-class margins and cash flow generation Ingevity Corporation (NYSE:NGVT) today announced it has completed the company's previously disclosed portfolio review process and is in the early stages of exploring strategic alternatives for its Advanced Polymer Technologies (APT) segment and Performance Chemicals Road Markings business, including a potential sale of one or both. "Ingevity's leadership team and Board remain focused on unlocking long-term value for shareholders," said Dave Li, president and CEO of Ingevity. "Having conducted a thorough review of the Ingevity portfolio, we have dete
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13G/A - Ingevity Corp (0001653477) (Subject)
SC 13D/A - Ingevity Corp (0001653477) (Subject)